Investment Week is hosting its Global Emerging Markets Briefing at a pivotal time for investors as they start to position for the recovery from the Covid-19 pandemic, although risks remain.
During this interactive briefing, we will hear from a number of global emerging market managers about their response to the extraordinary events of the past year and their outlook for the rest of the year and beyond.
The managers will identify where they are seeing the biggest opportunities and risks at the moment in emerging markets and explain the role their strategies could play in client portfolios.
Attendees will also get the chance to network with peers, quiz our speakers, as well as benefit from CPD points
As the country gears up to carry out two million vaccinations a week, you could be forgiven for thinking that investing in healthcare might be a smart move right now.
But while it s true that the extraordinary scientific advances of the last year have rightly made superstars out of women and men in white coats – the likes of Oxford University s Sarah Gilbert and BioNTech founders Ugur Sahin and Ozlem Tureci – it hasn t necessarily given a shot in the arm to those who have bought into big pharmaceutical businesses.
The sector was a standout performer in the first half of 2020, but it underperformed in the second, particularly in the UK.